Trailing-twelve-month (TTM) revenue is $404.53 Million with a year-over-year growth of (42.49%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $132,681,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q4 FY2025Period ended 2025-12-31 | $114,118,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-24 |
| Q1 FY2026Period ended 2026-03-31 | $80,075,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $77,653,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $404,527,000 |
Current P/S: $14,836,543 market capitalization ÷ $404,527,000 TTM revenue = 0.04x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T19:55:15.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $77.65M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:58:19.121Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD |
|---|---|
| Other Operating Segment | $24M |
$404.53M
$404.53 Million
(42.49%)
vs. $703.40M a year ago (TTM)
(17.71%)
5 Year compound annual growth rate
1 Year
(42.49%)
3 Year
(44.27%)
5 Year
(17.71%)
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $567.81M | ($351.01M) | (38.20%) |
| 2024 | $918.82M | ($395.59M) | (30.10%) |
| 2023 | $1.31B | ($2.64B) | (66.74%) |
| 2022 | $3.95B | +$1.88B | +90.89% |
| 2021 | $2.07B | +$1.01B | +94.54% |
| 2020 |
TTM Growth
(42.49%)
3-Year CAGR
(44.27%)
5-Year CAGR
(17.71%)
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T19:58:19.121Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $1.06B |
| ($11.63M) |
| (1.08%) |
| 2019 | $1.08B | +$219.92M | +25.69% |
